Cargando…
Competition and price among brand-name drugs in the same class: A systematic review of the evidence
BACKGROUND: Some experts have proposed combating rising drug prices by promoting brand–brand competition, a situation that is supposed to arise when multiple US Food and Drug Administration (FDA)-approved brand-name products in the same class are indicated for the same condition. However, numerous r...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667132/ https://www.ncbi.nlm.nih.gov/pubmed/31361747 http://dx.doi.org/10.1371/journal.pmed.1002872 |